Q1 2019 FibroGen Inc Earnings Call Transcript
Welcome to the FibroGen First 2019 Financial Results Conference Call. My name is Erin, and I will be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded. I will now turn the call over to Karen Bergman. Ms. Bergman, you may begin.
Erin, thank you very much. And good afternoon, everyone, and thank you for joining our call. Today, we are reporting financial results and corporate updates for the first quarter of 2019.
Joining today's call are Mr. Tom Neff, Chairman and Chief Executive Officer; Dr. Peony Yu, Chief Medical Officer; Dr. Elias Kouchakji, Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance; and Mr. Pat Cotroneo, Chief Financial Officer.
Following prepared remarks, Tom will discuss upcoming milestones, and we'll open the call to Q&A.
During this call, you may -- we may make forward-looking statements regarding our business, including our collaborations with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
